Rainer Fietkau

29PUBLICATIONS
73CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)NanophotonicsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Dec 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data.

Michael I Sponfeldner, Pauline Dürr, Phyllis Lensker

|Aug 14, 2025
Quality of Life Identifies High-Risk Groups in Advanced Rectal Cancer Patients.

Anna-Lena Zollner, Daniel Blasko, Tim Fitz

|Aug 13, 2025
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.

Rainer Fietkau, Michael Ghadimi, Robert Grützmann

|Feb 26, 2025
Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells.

Marzena Szwed, Tina Jost, Emilia Majka

|Nov 09, 2024
Change in Quality of Life in Patients with Advanced Rectal Cancer Between 2010 and 2022.

Ailina Doelz, Daniel Blasko, Claudia Schweizer

|Jun 19, 2024
Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and Niraparib.

Jacob Mentzel, Laura S Hildebrand, Lukas Kuhlmann

Pageof 5

Frequent Collaborators

14 joint publications

Luitpold Valentin Distel

6 joint publications

Florian Putz

6 joint publications

Udo S Gaipl

5 joint publications

Laura S Hildebrand